Literature DB >> 6444662

Interferon as a mediator of human lymphocyte suppression.

A S Kadish, F A Tansey, G S Yu, A T Doyle, B R Bloom.   

Abstract

Evidence is presented that interferon (IF) is a major mediator of the human concanavalin A (Con A) suppressor cell. The suppressive effects of Con A-activated lymphocytes on the mitogen responses of normal responder cells were largely abrogated by addition of anti-human leukocyte IF serum. Similar suppressor activity was generated by coculture of peripheral blood leukocytes (PBL) with a melanoma cell line (MeWo) and a HeLa cell line persistently infected with measles virus that induced the production of IF by lymphocytes. A human mammary carcinoma line (MCF-7) and two bladder carcinoma lines (T24 and TCCSUP) failed to induce IF or suppression. Addition of anti-human leukocyte IF serum to suppressor cells and supernates from tumor cell-lymphocyte cocultures largely abolished suppression and neutralized the antiviral activity of such supernates. Exposure of PBL from purified protein derivative (PPD)-positive donors to PPD caused the production of suppressor activity and IF. PBL from PPD-negative donors failed to produce significant amounts of IF or to suppress on exposure to PPD. Supernates from PBL treated with virus (Newcastle disease virus [NDV]) contained IF and suppressed the mitogen responses of responder PBL. Both the suppressive and the antiviral activities of this material were eliminated after treatment with anti-IF serum. To ascertain whether antiviral and suppressive activities were mediated by the same types of IF, supernates from PBL cultured with Con A, PPD, NDV, and tumor cells were treated with anti-IF serum or acid pH. In all cases antiviral activity was neutralized in parallel with abrogation of suppressor activity. These results provide strong evidence for the role of IF as a mediator of human suppressor cell activity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6444662      PMCID: PMC2185811          DOI: 10.1084/jem.151.3.637

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  Biological expressions of lymphocyte activation. IV. Concanavalin A-activated suppressor cells in mouse mixed lymphocyte reactions.

Authors:  R R Rich; S S Rich
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

2.  Biological expressions of lymphocyte activation. 3. Suppression of plaque-forming cell responses in vitro by supernatant fluids from concanavalin A-activated spleen cell cultures.

Authors:  R R Rich; C W Pierce
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

3.  Fluorescence-activated cell sorting of human T and B lymphocytes. II. Identification of the cell type responsible for interferon production and cell proliferation in response to mitogens.

Authors:  L B Epstein; H W Kreth; L A Herzenberg
Journal:  Cell Immunol       Date:  1974-06       Impact factor: 4.868

4.  A human cell line from a pleural effusion derived from a breast carcinoma.

Authors:  H D Soule; J Vazguez; A Long; S Albert; M Brennan
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

5.  Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

Authors:  J Bubeník; M Baresová; V Viklický; J Jakoubková; H Sainerová; J Donner
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

6.  Poliovirus replication and cytopathogenicity in monolayer hamster cell cultures fused with beta propiolactone-inactivated Sendai virus.

Authors:  J M Neff; J F Enders
Journal:  Proc Soc Exp Biol Med       Date:  1968-01

7.  Enhancement of phagocytosis by interferon-containing preparations.

Authors:  K Y Huang; R M Donahoe; F B Gordon; H R Dressler
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

8.  Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells.

Authors:  P Lindahl; P Leary; I Gresser
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

9.  Two antigenically distinct species of human interferon.

Authors:  E A Havell; B Berman; C A Ogburn; K Berg; K Paucker; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

10.  Inhibitory and stimulatory effects of concanavalin A on the response of mouse spleen cell suspensions to antigen. I. Characterization of the inhibitory cell activity.

Authors:  R W Dutton
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  20 in total

1.  Human suppressor T lymphocyte growth and differentiation.

Authors:  R R Rich; M N Elmasry; E J Fox
Journal:  Trans Am Clin Climatol Assoc       Date:  1988

2.  Factors affecting the autologous mixed lymphocyte reaction in kidney transplantation.

Authors:  L Fuller; C Flaa; D Jaffe; J Strauss; G K Kyriakides; J Miller
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

3.  Mechanism of suppression of lymphocyte proliferation by Concanavalin A-activated mononuclear cells.

Authors:  R Lomnitzer; A R Rabson
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

4.  Separation of concanavalin A-induced human suppressor and helper T cells by the autologous erythrocyte rosette technique.

Authors:  T Sakane; M Honda; Y Taniguchi; H Kotani
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

5.  Characterization of a soluble suppressor of human B cell immunoglobulin biosynthesis produced by a continuous human suppressor T cell line.

Authors:  T A Fleisher; W C Greene; T Uchiyama; C K Goldman; D L Nelson; R M Blaese; T A Waldmann
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307

6.  Proceedings of the British Thoracic Society. 1985 summer meeting. 3-5 July, York. Abstracts.

Authors: 
Journal:  Thorax       Date:  1985-09       Impact factor: 9.139

7.  Modulation of polyclonal B cell differentiation by human leucocyte alpha interferon.

Authors:  A I Levinson; A Dziarski; J J Hooks
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

8.  Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  P A Neighbour; A I Grayzel
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

9.  Insensitivity to interferon of NK cells from patients with systemic lupus erythematosus.

Authors:  P Fitzharris; J Alcocer; H A Stephens; R A Knight; M L Snaith
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

Review 10.  The interferons.

Authors:  J L Toy
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.